Skip to main content

Find Clinical Trials

Home
Conditions
COVID-19 Vaccine

Clinical trial condition

COVID-19 Vaccine

Explore clinical trials studying COVID-19 Vaccine. Study availability and eligibility vary by location and protocol.

28 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

COVID-19 Vaccine trial results

Completed

Serological Response to mRNA and Inactivated COVID-19 Vaccine in Health Care Workers in Hong Kong

NCT04898946

Conditions: COVID-19 Vaccine
Locations: Hong Kong Sanatorium & Hospital Hong Kong

View Trial Details

Completed

Covid-19 Vaccine Response in Heart Transplant Recipients

NCT05268679

Conditions: COVID-19, COVID-19 Vaccine, COVID-19 Virus Infection, +12 more
Locations: AP-HP, Bichat-Claude Bernard Hospital Paris, France

View Trial Details

Completed

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

NCT05656508

Conditions: COVID-19 Vaccine
Locations: Unidad de Investigación Clínica Farmacocinética FP Clinical Pharma en Clínica CIAREC Buenos Aires, Argentina

View Trial Details

Completed

ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

NCT05752201

Conditions: COVID-19 Vaccine
Locations: Fundación Huesped Buenos Aires, Buenos Aires F.D., Argentina

Centro de Investigaciones Clínicas Belgrano (CICB) Buenos Aires, Buenos Aires F.D., Argentina

Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno" - CEMIC Argentina, C.a.b.a.

Clinica Privada del Sol Córdoba, Córdoba Province, Argentina

View Trial Details

Completed

A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222

NCT05426343

Conditions: COVID-19 Vaccine
Locations: Hospital Fundación Tesai Ciudad del Este, Paraguay

View Trial Details

Completed

A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above

NCT05198596

Conditions: COVID-19 Vaccine
Locations: College of Medicine and Public Health, Ubon Ratchathani University Warin Chamrap, Changwat Ubon Ratchathani, Thailand

Sunpasitthiprasong Hospital Ubon Ratchathani, Thailand

View Trial Details

Completed

Host Immune Response to Novel RNA COVID-19 Vaccination

NCT04784689

Conditions: COVID-19 Vaccine, Cancer, Neoplasms
Locations: Mays Cancer Center, UT Health San Antonio San Antonio, Texas, United States

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19

NCT05216601

Conditions: COVID-19 Vaccine
Locations: Taipei Medical University Hospital Taipei, Taiwan

Tri-Service General Hospital Taipei, Taiwan

View Trial Details

Completed

A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19

NCT05197153

Conditions: COVID-19 Vaccine
Locations: Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

National Taiwan University Hospital Taipei, Taiwan

Taipei Municipal Wan Fang Hospital Taipei, Taiwan

Taipei Veteran General Hospital Taipei, Taiwan

View Trial Details

Completed

Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC

NCT04691947

Conditions: COVID-19, COVID-19 Vaccine, Coronaviridae Infections, +10 more
Locations: Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP) Kayseri, Turkey (Türkiye)

View Trial Details